Search

Your search keyword '"Balleine, R"' showing total 131 results

Search Constraints

Start Over You searched for: Author "Balleine, R" Remove constraint Author: "Balleine, R"
131 results on '"Balleine, R"'

Search Results

1. 16P Response to taxanes in low-grade serous ovarian cancer patients and cell lines

2. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

3. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

4. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

5. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

6. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

7. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

8. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

9. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

10. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

11. Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)

13. Development and validation of a targeted gene sequencing panel for application to disparate cancers

14. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

15. Two truncating variants in FANCC and breast cancer risk

16. Homologous recombination DNA repair defects in PALB2-associated breast cancers

17. Homologous recombination DNA repair defects in PALB2-associated breast cancers

18. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

21. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

22. Homologous recombination DNA repair defects in PALB2-associated breast cancers.

23. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

24. Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9).

25. Two truncating variants in FANCC and breast cancer risk

26. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

27. Homologous recombination DNA repair defects in PALB2-associated breast cancers (vol 5, 23, 2019)

28. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

30. Heritable DNA methylation marks associated with susceptibility to breast cancer /631/67/69 /631/337/176/1988 /692/699/67/1347 /692/308/2056 /45 /45/61 article.

31. Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

32. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

33. RAD51B in familial breast cancer.

34. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

35. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

36. Identification of novel genetic markers of breast cancer survival

37. Common germline polymorphisms\ud associated with breast cancer-specific survival

38. Identification of novel genetic markers of breast cancer survival

39. Refined histopathological predictors of BRCA1\ud and BRCA2 mutation status: a large-scale analysis\ud of breast cancer characteristics from the BCAC,\ud CIMBA, and ENIGMA consortia

40. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

41. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

42. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

43. Prediction of breast cancer risk based on profiling with common genetic variants

44. Identification of novel genetic markers of breast cancer survival

45. Common germline polymorphisms associated with breast cancer-specific survival

46. Common germline polymorphisms associated with breast cancer-specific survival

47. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

48. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer

49. Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer

50. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Catalog

Books, media, physical & digital resources